Can we change the rules of medicine?

Episode 201

0:00-30:22

Advances in genomics are making it possible to develop treatments for individual patients with rare genetic conditions. But how can we get these treatments to the people who need them when traditional medicine development is designed for much larger groups of patients? In this episode, our guests explore the challenges of developing and approving personalised medicines, and how researchers, regulators and patient advocates can work together to bridge the gap between scientific advances and patient access. Our host Sharon Jones is joined by: Dr Dan O’Connor, Executive Director Regulatory, Association of the British Pharmaceutical Industry (ABPI) Julia Vitarello, founder and CEO of Mila’s Miracles Foundation Professor Rich Scott, CEO of Genomics England If you enjoyed today’s conversation, please like and share wherever you listen to your podcasts. “The technology's there, and it's now just saying, "Well, actually, can the system catch up?" And that's really the clear message I think we have to do. We've got to somehow align with the fast-evolving opportunities that new technology will offer us, and ensure that patients get the medicines they really need.” You can download the transcript, or read it below. Sharon Jones: Hello and welcome to Behind the Genes, the podcast that brings you the stories, research, and innovations shaping the future of genomic healthcare.

Publisher

Behind the Genes

Link

genomicsengland.podbean.com/e/can-we-change-the-rules-of-medicine/

Published

October 28, 2026

Duration

30 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Genomics England

BT

Behind the Genes

@behindthegenes

#change #rules #medicine #lifesciences #socialsciences

The Nile